EC Number | Activating Compound | Comment | Organism | Structure |
---|---|---|---|---|
3.2.1.22 | EDTA | 16% increase in activity | Bifidobacterium breve | |
3.2.1.22 | NH4+ | 23% increase in activity | Bifidobacterium breve |
EC Number | Cloned (Comment) | Organism |
---|---|---|
3.2.1.22 | - |
Bifidobacterium breve |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
3.2.1.22 | Ag+ | strong | Bifidobacterium breve | |
3.2.1.22 | Cu2+ | strong | Bifidobacterium breve | |
3.2.1.22 | Hg2+ | strong | Bifidobacterium breve |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
3.2.1.22 | 0.27 | - |
4-nitrophenyl-alpha-D-galactopyranoside | - |
Bifidobacterium breve | |
3.2.1.22 | 4.3 | - |
melibiose | - |
Bifidobacterium breve |
EC Number | Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
---|---|---|---|---|
3.2.1.22 | 80500 | - |
2 * 81500, calculated, 2 * 80500, SDS-PAGE | Bifidobacterium breve |
3.2.1.22 | 81500 | - |
2 * 81500, calculated, 2 * 80500, SDS-PAGE | Bifidobacterium breve |
3.2.1.22 | 152000 | - |
PAGE | Bifidobacterium breve |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
3.2.1.22 | Bifidobacterium breve | Q2XQ11 | - |
- |
3.2.1.22 | Bifidobacterium breve 203 | Q2XQ11 | - |
- |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
3.2.1.22 | 2-nitrophenyl alpha-D-galactopyranoside + H2O | - |
Bifidobacterium breve | 2-nitrophenol + D-galactopyranose | 16.5% of the activity with 4-nitrophenyl-alpha-D-galactopyranoside | ? | |
3.2.1.22 | 2-nitrophenyl alpha-D-galactopyranoside + H2O | - |
Bifidobacterium breve 203 | 2-nitrophenol + D-galactopyranose | 16.5% of the activity with 4-nitrophenyl-alpha-D-galactopyranoside | ? | |
3.2.1.22 | 3-nitrophenyl-alpha-D-galactopyranoside + H2O | - |
Bifidobacterium breve | 3-nitrophenol + D-galactopyranose | 5.6% of the activity with 4-nitrophenyl-alpha-D-galactopyranoside | ? | |
3.2.1.22 | 3-nitrophenyl-alpha-D-galactopyranoside + H2O | - |
Bifidobacterium breve 203 | 3-nitrophenol + D-galactopyranose | 5.6% of the activity with 4-nitrophenyl-alpha-D-galactopyranoside | ? | |
3.2.1.22 | 4-nitrophenyl-alpha-D-galactopyranoside + H2O | - |
Bifidobacterium breve | 4-nitrophenol + D-galactopyranose | - |
? | |
3.2.1.22 | melibiose + H2O | - |
Bifidobacterium breve | D-galactose + D-glucose | - |
? | |
3.2.1.22 | melibiose + H2O | - |
Bifidobacterium breve 203 | D-galactose + D-glucose | - |
? | |
3.2.1.22 | additional information | enzyme additionally catalyzes transglycosylation. It is able to synthesize a trisaccharide galactose-(alpha-1,4)-galactose(alpha-1,6)-glucose using melibiose as substrate. In presence of 4-nitrophenyl-alpha-D-galactopyranoside, enzyme catalyzes glycosyl transfer to various acceptors | Bifidobacterium breve | ? | - |
? | |
3.2.1.22 | additional information | no substrate: 3-nitrophenyl-beta-D-galactopyranoside, 4-nitrophenyl-beta-D-galactopyranoside, 4-nitrophenyl-beta-D-galacturonide, 2-nitrophenyl-alpha-D-glucopyranoside, 2-nitrophenyl-beta-D-glucopyranoside, 4-nitrophenyl-alpha-L-fucopyranoside, 4-nitrophenyl-beta-D-fucopyranoside, 4-nitrophenyl-alpha-D-mannopyranoside, 4-nitrophenyl-beta-D-mannopyranoside, 4-nitrophenyl-2-(acetylamino)-2-deoxy-alpha-D-galactopyranoside, 4-nitrophenyl-2-(acetylamino)-2-deoxy-beta-D-galactopyranoside, and 2-nitrophenyl-2-(acetylamino)-2-deoxy-beta-D-galactopyranoside | Bifidobacterium breve | ? | - |
? | |
3.2.1.22 | additional information | enzyme additionally catalyzes transglycosylation. It is able to synthesize a trisaccharide galactose-(alpha-1,4)-galactose(alpha-1,6)-glucose using melibiose as substrate. In presence of 4-nitrophenyl-alpha-D-galactopyranoside, enzyme catalyzes glycosyl transfer to various acceptors | Bifidobacterium breve 203 | ? | - |
? | |
3.2.1.22 | additional information | no substrate: 3-nitrophenyl-beta-D-galactopyranoside, 4-nitrophenyl-beta-D-galactopyranoside, 4-nitrophenyl-beta-D-galacturonide, 2-nitrophenyl-alpha-D-glucopyranoside, 2-nitrophenyl-beta-D-glucopyranoside, 4-nitrophenyl-alpha-L-fucopyranoside, 4-nitrophenyl-beta-D-fucopyranoside, 4-nitrophenyl-alpha-D-mannopyranoside, 4-nitrophenyl-beta-D-mannopyranoside, 4-nitrophenyl-2-(acetylamino)-2-deoxy-alpha-D-galactopyranoside, 4-nitrophenyl-2-(acetylamino)-2-deoxy-beta-D-galactopyranoside, and 2-nitrophenyl-2-(acetylamino)-2-deoxy-beta-D-galactopyranoside | Bifidobacterium breve 203 | ? | - |
? |
EC Number | Subunits | Comment | Organism |
---|---|---|---|
3.2.1.22 | dimer | 2 * 81500, calculated, 2 * 80500, SDS-PAGE | Bifidobacterium breve |
EC Number | Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
---|---|---|---|---|
3.2.1.22 | 50 | - |
- |
Bifidobacterium breve |
EC Number | Temperature Stability Minimum [°C] | Temperature Stability Maximum [°C] | Comment | Organism |
---|---|---|---|---|
3.2.1.22 | 50 | - |
stable below | Bifidobacterium breve |
EC Number | pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
---|---|---|---|---|
3.2.1.22 | 5.5 | - |
- |
Bifidobacterium breve |
EC Number | pH Stability | pH Stability Maximum | Comment | Organism |
---|---|---|---|---|
3.2.1.22 | 4.5 | 9 | - |
Bifidobacterium breve |